Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of COVID-19 with diabetes: a systematic review and meta-analysis
Paddy Ssentongo, Yue Zhang, Lisa Witmer, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis
Honghao Lai, Manli Yang, Mingyao Sun, et al.
Metabolism (2022) Vol. 137, pp. 155330-155330
Open Access | Times Cited: 39
State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease
Elizabeth M. Rhea, Manon Leclerc, Hussein N. Yassine, et al.
Aging and Disease (2023)
Open Access | Times Cited: 33
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies
Masoud Rahmati, Dong Keon Yon, Seung Won Lee, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 27
New-Onset Diabetes After COVID-19
Sun H. Kim, Ipsa Arora, Daniel S. Hsia, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 11, pp. e1164-e1174
Closed Access | Times Cited: 25
Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies
Juan Víctor Ariel Franco, Luis Garegnani, Maria‐Inti Metzendorf, et al.
BMJ Medicine (2024) Vol. 3, Iss. 1, pp. e000723-e000723
Open Access | Times Cited: 13
Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
Pasquale Mone, Stanislovas S. Jankauskas, Maria Virginia Manzi, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 1, pp. 34-39
Open Access | Times Cited: 8
Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence
Rachel Wong, Emily K.Y. Lam, Carolyn T. Bramante, et al.
Current Diabetes Reports (2023) Vol. 23, Iss. 8, pp. 207-216
Open Access | Times Cited: 20
Incident autoimmune diseases in association with a SARS-CoV-2 infection: A matched cohort study
Falko Tesch, Franz Ehm, Annika Vivirito, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study
Raffaele Izzo, Daniela Pacella, Valentina Trimarco, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102345-102345
Open Access | Times Cited: 16
Associations of diabetes, hypertension and obesity with COVID-19 mortality: a systematic review and meta-analysis
Chaoyang Li, Nazrul Islam, Juan Pablo Gutiérrez, et al.
BMJ Global Health (2023) Vol. 8, Iss. 12, pp. e012581-e012581
Open Access | Times Cited: 15
Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis
Kunwadee Noonong, Moragot Chatatikun, Sirirat Surinkaew, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: A study using data from the UK Biobank
Yong Xiang, Yaning Feng, Jinghong Qiu, et al.
International Journal of Infectious Diseases (2024) Vol. 145, pp. 107080-107080
Open Access | Times Cited: 6
The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5
SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022
Mark Steven Miller, Pauline Terebuh, David C. Kaelber, et al.
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2439444-e2439444
Open Access | Times Cited: 5
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Future prevalence of type 2 diabetes in Germany: a projection until 2040 including incidence trends observed during the SARS-CoV-2 pandemic
Thaddäus Tönnies, Dina Voeltz, Stephan D. Voss, et al.
Frontiers in Epidemiology (2025) Vol. 5
Open Access
A Comprehensive Machine Learning Approach for Early Detection of Diabetes on Imbalanced Data with Missing and Outlier Values
Yogendra Singh, Mahendra Tiwari
SN Computer Science (2025) Vol. 6, Iss. 3
Closed Access
Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study
Farzana Afroze, Shohael Mahmud Arafat, Chowdhury Meshkat Ahmed, et al.
Journal of Global Health (2025) Vol. 15
Open Access
Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection
Raluca-Ileana Pătru, Miruna Ghigeanu, Maria-Alexandra Barbu, et al.
Reports — Medical Cases Images and Videos (2025) Vol. 8, Iss. 1, pp. 31-31
Open Access
COVID-19 and metabolic syndrome
Harsha Dissanayake
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101753-101753
Open Access | Times Cited: 14
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID‐19 patients: Comparison with influenza and pre‐pandemic data
Kevin Dell’Aquila, Jeylin Lee, Stephen Wang, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 9, pp. 2482-2494
Closed Access | Times Cited: 12
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review
Marielle Priscila de Paula Silva-Lalucci, Déborah Cristina de Souza Marques, Pablo Valdés-Badilla, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 543-543
Open Access | Times Cited: 4
Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis
Chiara Bellia, Aikaterini Andreadi, Ilenia D’Ippolito, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Integrative Plasma Metabolic and Lipidomic Modelling of SARS-CoV-2 Infection in Relation to Clinical Severity and Early Mortality Prediction
Samantha Lodge, Nathan G. Lawler, Nicola Gray, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11614-11614
Open Access | Times Cited: 10
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top